NO20062450L - Analgesiske suspensjoner med kontrollert frigivelse - Google Patents
Analgesiske suspensjoner med kontrollert frigivelseInfo
- Publication number
- NO20062450L NO20062450L NO20062450A NO20062450A NO20062450L NO 20062450 L NO20062450 L NO 20062450L NO 20062450 A NO20062450 A NO 20062450A NO 20062450 A NO20062450 A NO 20062450A NO 20062450 L NO20062450 L NO 20062450L
- Authority
- NO
- Norway
- Prior art keywords
- controlled release
- release analgesic
- suspensions
- analgesic suspensions
- acetaminophen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Dispersion Chemistry (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Det er beskrevet en fremgangsmåte for administiering av ikke-steroidale antiinflammatoriske legemidler, spesielt popionsyrederivater, så som ibuprofen eller acetaminofen ved hjelp av en flytende suspensjon. Derme fremgangsmåten tilveiebringer for bedre terapeutisk effekt, spesielt smertelindring, over utvidede tidsrom.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/697,546 US20050095299A1 (en) | 2003-10-30 | 2003-10-30 | Controlled release analgesic suspensions |
PCT/US2004/034709 WO2005044230A2 (en) | 2003-10-30 | 2004-10-21 | Controlled release analgesic suspensions |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20062450L true NO20062450L (no) | 2006-05-30 |
Family
ID=34550387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20062450A NO20062450L (no) | 2003-10-30 | 2006-05-30 | Analgesiske suspensjoner med kontrollert frigivelse |
Country Status (11)
Country | Link |
---|---|
US (1) | US20050095299A1 (no) |
EP (1) | EP1694297B1 (no) |
JP (1) | JP2007509937A (no) |
KR (1) | KR20060096492A (no) |
CN (1) | CN1874754A (no) |
BR (1) | BRPI0415628A (no) |
CA (1) | CA2543497C (no) |
ES (1) | ES2408308T3 (no) |
NO (1) | NO20062450L (no) |
RU (1) | RU2006118696A (no) |
WO (1) | WO2005044230A2 (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060093631A1 (en) * | 2004-10-29 | 2006-05-04 | Buehler Gail K | Dye-free pharmaceutical suspensions and related methods |
AU2005313365A1 (en) * | 2004-12-06 | 2006-06-15 | Janssen Pharmaceutica N.V. | Oral suspension comprising meloxicam |
US20090022798A1 (en) * | 2007-07-20 | 2009-01-22 | Abbott Gmbh & Co. Kg | Formulations of nonopioid and confined opioid analgesics |
US20090317355A1 (en) * | 2006-01-21 | 2009-12-24 | Abbott Gmbh & Co. Kg, | Abuse resistant melt extruded formulation having reduced alcohol interaction |
US20100172989A1 (en) * | 2006-01-21 | 2010-07-08 | Abbott Laboratories | Abuse resistant melt extruded formulation having reduced alcohol interaction |
US20080057122A1 (en) * | 2006-08-31 | 2008-03-06 | Aaipharma Inc. | Acetaminophen pharmaceutical compositions |
US9226907B2 (en) | 2008-02-01 | 2016-01-05 | Abbvie Inc. | Extended release hydrocodone acetaminophen and related methods and uses thereof |
AU2010211980A1 (en) * | 2009-01-09 | 2011-08-25 | Panacea Biotec Ltd. | Dual release pharmaceutical suspension |
US8529914B2 (en) | 2010-06-28 | 2013-09-10 | Richard C. Fuisz | Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive |
AU2012211036A1 (en) * | 2011-01-27 | 2013-08-22 | Mayne Pharma International Pty Ltd | Extended release acetaminophen liquid pharmaceutical compositions |
KR101561345B1 (ko) * | 2013-10-17 | 2015-10-16 | 대원제약주식회사 | 제어방출되는 프로피온산 계열의 약제학적 조성물 |
FR3027802B1 (fr) * | 2014-10-31 | 2018-03-02 | Ethypharm | Granules de principe actif a double masquage de gout, leur procede de preparation et comprimes orodispersibles les contenant |
CN108926530A (zh) * | 2018-08-17 | 2018-12-04 | 江苏科瑞达药业有限公司 | 一种具有高效混悬作用的对乙酰氨基酚液体制剂 |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3485719A (en) * | 1967-10-13 | 1969-12-23 | Us Agriculture | Continuous process for producing xanthomonas heteropolysaccharide |
GB1497044A (en) * | 1974-03-07 | 1978-01-05 | Prodotti Antibiotici Spa | Salts of phenyl-alkanoic acids |
US4221778A (en) * | 1979-01-08 | 1980-09-09 | Pennwalt Corporation | Prolonged release pharmaceutical preparations |
GB8317696D0 (en) * | 1983-06-29 | 1983-08-03 | Shell Int Research | Preparing xanthomonas heteroplysaccharide |
US4762709A (en) * | 1983-09-16 | 1988-08-09 | Pennwalt Corporation | Liquid prolonged release pharmaceutical formulations containing ionic constituents |
US4847077A (en) * | 1984-07-18 | 1989-07-11 | Pennwalt Corporation | Controlled release pharmaceutical preparations |
IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
US4873231A (en) * | 1986-04-08 | 1989-10-10 | Smith Walton J | Decreasing the toxicity of an ibuprofen salt |
JPS6327424A (ja) * | 1986-07-17 | 1988-02-05 | Shionogi & Co Ltd | 徐放性製剤およびその製造法 |
US4859461A (en) * | 1986-07-30 | 1989-08-22 | Fisons Corporation | Coatable ion exchange resins |
US4788220A (en) * | 1987-07-08 | 1988-11-29 | American Home Products Corporation (Del.) | Pediatric ibuprofen compositions |
US4861797A (en) * | 1987-10-15 | 1989-08-29 | Oratech Pharmaceutical Development Corporation | Liquid ibuprofen compositions and methods of making them |
GB8724763D0 (en) * | 1987-10-22 | 1987-11-25 | Aps Research Ltd | Sustained-release formulations |
DE3822095A1 (de) * | 1988-06-30 | 1990-01-04 | Klinge Co Chem Pharm Fab | Neue arzneimittelformulierung sowie verfahren zu deren herstellung |
US4906478A (en) * | 1988-12-12 | 1990-03-06 | Valentine Enterprises, Inc. | Simethicone/calcium silicate composition |
US4975465A (en) * | 1989-03-28 | 1990-12-04 | American Home Products Corporation | Orally administrable ibuprofen compositions |
US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
NZ234143A (en) * | 1989-06-28 | 1991-10-25 | Mcneil Ppc Inc | Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents |
US5527545A (en) * | 1989-09-18 | 1996-06-18 | Recordati S.A. Chemical And Pharmaceutical Company | Liquid-suspension controlled-release pharmaceutical composition |
US5275822A (en) * | 1989-10-19 | 1994-01-04 | Valentine Enterprises, Inc. | Defoaming composition |
IE66933B1 (en) * | 1990-01-15 | 1996-02-07 | Elan Corp Plc | Controlled absorption naproxen formulation for once-daily administration |
CA2061520C (en) * | 1991-03-27 | 2003-04-22 | Lawrence J. Daher | Delivery system for enhanced onset and increased potency |
US5183829A (en) * | 1991-09-27 | 1993-02-02 | Applied Analytical Industries, Inc. | Oral liquid compositions of non-steroidal anti-inflammatory drugs |
US5272137A (en) * | 1992-02-14 | 1993-12-21 | Mcneil-Pfc, Inc. | Aqueous pharmaceutical suspension for pharmaceutical actives |
FI941777A (fi) * | 1993-04-16 | 1994-10-17 | Mcneil Ppc Inc | Vesipitoinen farmaseuttinen suspensio ja menetelmä sen valmistamiseksi |
IT1264855B1 (it) * | 1993-06-21 | 1996-10-17 | Zambon Spa | Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici |
US5773031A (en) * | 1996-02-27 | 1998-06-30 | L. Perrigo Company | Acetaminophen sustained-release formulation |
US5759579A (en) * | 1996-12-05 | 1998-06-02 | American Home Products Corporation | Pharmaceutical suspension systems |
PT946145E (pt) * | 1996-12-20 | 2008-10-17 | Mcneil Ppc Inc | Fármacos antitússicos libertados por resinas de troca iónica |
US6103260A (en) * | 1997-07-17 | 2000-08-15 | Mcneil-Ppc, Inc. | Simethicone/anhydrous calcium phosphate compositions |
US5885616A (en) * | 1997-08-18 | 1999-03-23 | Impax Pharmaceuticals, Inc. | Sustained release drug delivery system suitable for oral administration |
AU9062998A (en) * | 1997-09-11 | 1999-03-29 | Nycomed Danmark A/S | Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids) |
US6197347B1 (en) * | 1998-06-29 | 2001-03-06 | Andrx Pharmaceuticals, Inc. | Oral dosage for the controlled release of analgesic |
US6270790B1 (en) * | 1998-08-18 | 2001-08-07 | Mxneil-Ppc, Inc. | Soft, convex shaped chewable tablets having reduced friability |
US6254891B1 (en) * | 1998-09-03 | 2001-07-03 | Ascent Pediatrics, Inc. | Extended release acetaminophen |
US6126967A (en) * | 1998-09-03 | 2000-10-03 | Ascent Pediatrics | Extended release acetaminophen particles |
IN191239B (no) * | 1999-06-11 | 2003-10-11 | Ranbaxy Lab Ltd | |
EP1239857B1 (en) * | 1999-12-22 | 2006-04-19 | Pharmacia Corporation | Dual-release compositions of a cyclooxygenase-2- inhibitor |
GB0009522D0 (en) * | 2000-04-19 | 2000-06-07 | Smithkline Beecham Plc | Composition |
US7223421B2 (en) * | 2000-06-30 | 2007-05-29 | Mcneil-Ppc, Inc. | Teste masked pharmaceutical particles |
AU2003271024A1 (en) * | 2002-09-21 | 2004-04-08 | Jin Wang | Sustained release compound of acetamidophenol and tramadol |
-
2003
- 2003-10-30 US US10/697,546 patent/US20050095299A1/en not_active Abandoned
-
2004
- 2004-10-21 KR KR1020067008415A patent/KR20060096492A/ko not_active Application Discontinuation
- 2004-10-21 WO PCT/US2004/034709 patent/WO2005044230A2/en active Application Filing
- 2004-10-21 RU RU2006118696/15A patent/RU2006118696A/ru not_active Application Discontinuation
- 2004-10-21 JP JP2006538094A patent/JP2007509937A/ja active Pending
- 2004-10-21 BR BRPI0415628-5A patent/BRPI0415628A/pt not_active IP Right Cessation
- 2004-10-21 ES ES04795819T patent/ES2408308T3/es active Active
- 2004-10-21 CN CNA2004800321539A patent/CN1874754A/zh active Pending
- 2004-10-21 CA CA2543497A patent/CA2543497C/en not_active Expired - Fee Related
- 2004-10-21 EP EP04795819.4A patent/EP1694297B1/en not_active Not-in-force
-
2006
- 2006-05-30 NO NO20062450A patent/NO20062450L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2005044230A3 (en) | 2005-08-18 |
CA2543497C (en) | 2013-02-26 |
BRPI0415628A (pt) | 2006-12-12 |
JP2007509937A (ja) | 2007-04-19 |
EP1694297B1 (en) | 2013-04-10 |
KR20060096492A (ko) | 2006-09-11 |
CA2543497A1 (en) | 2005-05-19 |
CN1874754A (zh) | 2006-12-06 |
US20050095299A1 (en) | 2005-05-05 |
EP1694297A2 (en) | 2006-08-30 |
WO2005044230A2 (en) | 2005-05-19 |
RU2006118696A (ru) | 2007-12-10 |
ES2408308T3 (es) | 2013-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20062450L (no) | Analgesiske suspensjoner med kontrollert frigivelse | |
NO20062442L (no) | Analgesiske suspensjoner md kontrollert frigivelse | |
EA200501849A1 (ru) | Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ | |
MY142589A (en) | Benzimidazole derivatives : preparation and pharmaceutical applications | |
DK1519724T3 (da) | Fredericamycin-derivater som lægemidler til behandling af tumorer | |
EP1961748A3 (en) | 2-Hydroxy-3-heteroarylindole derivatives as GSK3 inhibitors | |
IN2015DN01132A (no) | ||
BRPI0512974A (pt) | novos derivados de hidantoìna para o tratamento de doenças obstrutivas das vias aéreas | |
NO20065904L (no) | Terapeutiske forbindelser | |
NO20061506L (no) | Heterocykliske inhibitorer av MEK og fremgangsmater for anvendelse derav | |
EA200801243A1 (ru) | Фармацевтическое применение замещенных амидов | |
NO20065878L (no) | Terapeutiske forbindelser | |
BR0315580A (pt) | Derivados de metileno uréia | |
NO20076425L (no) | Fremgangsmater for behandling av drug-resistent cancer | |
NO20054646L (no) | Doseringskur for ikke-steroidalt anti-inflammatorisk legemiddel | |
UA89067C2 (ru) | Производные гидантоина, полезные как ингибиторы металлопротеиназ | |
WO2003048122A3 (en) | Inhibitors of cytosolic phospholipase a2 | |
DK1594885T3 (da) | Lægemiddel til vækstinhibering af tumorer | |
NO20080372L (no) | Pyrazolderivater som teraputiske midler | |
EA200401319A1 (ru) | Новые гетероциклические соединения, способы их получения и фармацевтические композиции, содержащие эти соединения, и их использование в медицине | |
BR112021022255A2 (pt) | Composto usado como inibidor de quinase e aplicação do mesmo | |
EA200900269A1 (ru) | Лекарственные комбинации для лечения заболеваний дыхательных путей | |
EA200500942A1 (ru) | Средство для лечения болезней суставов | |
NO20055889L (no) | 2-etoksy-3-fenylpropansyrederivater for behandling av fettforstyrrelser | |
WO2006004507A3 (en) | New benzothiazole derivatives useful for treating cns disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |